Logo image of XRX

XEROX HOLDINGS CORP (XRX) Stock Fundamental Analysis

USA - NASDAQ:XRX - US98421M1062 - Common Stock

3.75 USD
-0.03 (-0.79%)
Last: 10/3/2025, 8:13:37 PM
3.8098 USD
+0.06 (+1.59%)
After Hours: 10/3/2025, 8:13:37 PM
Fundamental Rating

3

Overall XRX gets a fundamental rating of 3 out of 10. We evaluated XRX against 33 industry peers in the Technology Hardware, Storage & Peripherals industry. XRX has a bad profitability rating. Also its financial health evaluation is rather negative. XRX has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year XRX has reported negative net income.
In the past year XRX had a positive cash flow from operations.
In the past 5 years XRX reported 4 times negative net income.
Each year in the past 5 years XRX had a positive operating cash flow.
XRX Yearly Net Income VS EBIT VS OCF VS FCFXRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B 1.5B

1.2 Ratios

Looking at the Return On Assets, with a value of -16.18%, XRX is doing worse than 60.61% of the companies in the same industry.
XRX has a worse Return On Equity (-107.49%) than 63.64% of its industry peers.
The Return On Invested Capital of XRX (1.60%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for XRX is significantly below the industry average of 14.92%.
Industry RankSector Rank
ROA -16.18%
ROE -107.49%
ROIC 1.6%
ROA(3y)-6.33%
ROA(5y)-4.27%
ROE(3y)-37.8%
ROE(5y)-24.09%
ROIC(3y)2.67%
ROIC(5y)2.81%
XRX Yearly ROA, ROE, ROICXRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80 -100

1.3 Margins

XRX has a Operating Margin (2.12%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of XRX has declined.
XRX has a Gross Margin (30.35%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of XRX has declined.
Industry RankSector Rank
OM 2.12%
PM (TTM) N/A
GM 30.35%
OM growth 3Y-20.2%
OM growth 5Y-27.38%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.91%
GM growth 5Y-4.79%
XRX Yearly Profit, Operating, Gross MarginsXRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so XRX is destroying value.
Compared to 1 year ago, XRX has more shares outstanding
The number of shares outstanding for XRX has been reduced compared to 5 years ago.
XRX has a worse debt/assets ratio than last year.
XRX Yearly Shares OutstandingXRX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
XRX Yearly Total Debt VS Total AssetsXRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

Based on the Altman-Z score of 1.45, we must say that XRX is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of XRX (1.45) is comparable to the rest of the industry.
XRX has a debt to FCF ratio of 13.05. This is a negative value and a sign of low solvency as XRX would need 13.05 years to pay back of all of its debts.
XRX has a Debt to FCF ratio of 13.05. This is comparable to the rest of the industry: XRX outperforms 51.52% of its industry peers.
XRX has a Debt/Equity ratio of 2.61. This is a high value indicating a heavy dependency on external financing.
XRX's Debt to Equity ratio of 2.61 is on the low side compared to the rest of the industry. XRX is outperformed by 72.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.61
Debt/FCF 13.05
Altman-Z 1.45
ROIC/WACC0.28
WACC5.71%
XRX Yearly LT Debt VS Equity VS FCFXRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

XRX has a Current Ratio of 1.46. This is a normal value and indicates that XRX is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of XRX (1.46) is comparable to the rest of the industry.
A Quick Ratio of 1.10 indicates that XRX should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.10, XRX perfoms like the industry average, outperforming 57.58% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.46
Quick Ratio 1.1
XRX Yearly Current Assets VS Current LiabilitesXRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2

3. Growth

3.1 Past

The earnings per share for XRX have decreased strongly by -107.26% in the last year.
Measured over the past years, XRX shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -25.94% on average per year.
Looking at the last year, XRX shows a decrease in Revenue. The Revenue has decreased by -4.97% in the last year.
XRX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -7.26% yearly.
EPS 1Y (TTM)-107.26%
EPS 3Y-14.01%
EPS 5Y-25.94%
EPS Q2Q%-320.69%
Revenue 1Y (TTM)-4.97%
Revenue growth 3Y-4.03%
Revenue growth 5Y-7.26%
Sales Q2Q%-0.13%

3.2 Future

The Earnings Per Share is expected to grow by 14.60% on average over the next years. This is quite good.
The Revenue is expected to decrease by -0.46% on average over the next years.
EPS Next Y-46.24%
EPS Next 2Y22.37%
EPS Next 3Y14.6%
EPS Next 5YN/A
Revenue Next Year12.74%
Revenue Next 2Y10.51%
Revenue Next 3Y6.25%
Revenue Next 5Y-0.46%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
XRX Yearly Revenue VS EstimatesXRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B 20B
XRX Yearly EPS VS EstimatesXRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for XRX. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 2.61, the valuation of XRX can be described as very cheap.
XRX's Price/Forward Earnings ratio is rather cheap when compared to the industry. XRX is cheaper than 93.94% of the companies in the same industry.
XRX is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.32, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 2.61
XRX Price Earnings VS Forward Price EarningsXRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, XRX is valued cheaply inside the industry as 87.88% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, XRX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 1.56
EV/EBITDA 9.81
XRX Per share dataXRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

A more expensive valuation may be justified as XRX's earnings are expected to grow with 14.60% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.37%
EPS Next 3Y14.6%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.65%, XRX has a reasonable but not impressive dividend return.
The stock price of XRX dropped by -34.21% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
XRX's Dividend Yield is rather good when compared to the industry average which is at 2.15. XRX pays more dividend than 93.94% of the companies in the same industry.
XRX's Dividend Yield is comparable with the S&P500 average which is at 2.41.
Industry RankSector Rank
Dividend Yield 2.65%

5.2 History

The dividend of XRX has a limited annual growth rate of 0.72%.
XRX has been paying a dividend for at least 10 years, so it has a reliable track record.
XRX has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)0.72%
Div Incr Years0
Div Non Decr Years6
XRX Yearly Dividends per shareXRX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

The earnings of XRX are negative and hence is the payout ratio. XRX will probably not be able to sustain this dividend level.
XRX's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-8.91%
EPS Next 2Y22.37%
EPS Next 3Y14.6%
XRX Yearly Income VS Free CF VS DividendXRX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

XEROX HOLDINGS CORP

NASDAQ:XRX (10/3/2025, 8:13:37 PM)

After market: 3.8098 +0.06 (+1.59%)

3.75

-0.03 (-0.79%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)10-28 2025-10-28/bmo
Inst Owners99.89%
Inst Owner Change32.86%
Ins Owners7.73%
Ins Owner Change14.76%
Market Cap471.86M
Analysts47.27
Price Target7.96 (112.27%)
Short Float %20.3%
Short Ratio4.62
Dividend
Industry RankSector Rank
Dividend Yield 2.65%
Yearly Dividend1.14
Dividend Growth(5Y)0.72%
DP-8.91%
Div Incr Years0
Div Non Decr Years6
Ex-Date09-30 2025-09-30 (0.025)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-495.05%
Min EPS beat(2)-892.08%
Max EPS beat(2)-98.02%
EPS beat(4)0
Avg EPS beat(4)-268.42%
Min EPS beat(4)-892.08%
Max EPS beat(4)-32.32%
EPS beat(8)1
Avg EPS beat(8)-147.42%
EPS beat(12)4
Avg EPS beat(12)-77.28%
EPS beat(16)7
Avg EPS beat(16)-65.19%
Revenue beat(2)1
Avg Revenue beat(2)-1.37%
Min Revenue beat(2)-3.7%
Max Revenue beat(2)0.96%
Revenue beat(4)2
Avg Revenue beat(4)-2.03%
Min Revenue beat(4)-7%
Max Revenue beat(4)1.64%
Revenue beat(8)2
Avg Revenue beat(8)-2.53%
Revenue beat(12)3
Avg Revenue beat(12)-1.95%
Revenue beat(16)4
Avg Revenue beat(16)-1.9%
PT rev (1m)-6.02%
PT rev (3m)-23.53%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-36.09%
EPS NY rev (1m)0%
EPS NY rev (3m)-32.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)20.7%
Revenue NY rev (1m)3.69%
Revenue NY rev (3m)12.33%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 2.61
P/S 0.08
P/FCF 1.56
P/OCF 1.29
P/B 0.35
P/tB N/A
EV/EBITDA 9.81
EPS(TTM)-0.09
EYN/A
EPS(NY)1.44
Fwd EY38.34%
FCF(TTM)2.4
FCFY64%
OCF(TTM)2.92
OCFY77.78%
SpS49.07
BVpS10.62
TBVpS-6.91
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.18%
ROE -107.49%
ROCE 2.03%
ROIC 1.6%
ROICexc 1.73%
ROICexgc 2.73%
OM 2.12%
PM (TTM) N/A
GM 30.35%
FCFM 4.89%
ROA(3y)-6.33%
ROA(5y)-4.27%
ROE(3y)-37.8%
ROE(5y)-24.09%
ROIC(3y)2.67%
ROIC(5y)2.81%
ROICexc(3y)2.95%
ROICexc(5y)3.28%
ROICexgc(3y)5.26%
ROICexgc(5y)5.88%
ROCE(3y)3.38%
ROCE(5y)3.56%
ROICexcg growth 3Y-8.95%
ROICexcg growth 5Y-26.16%
ROICexc growth 3Y-9.42%
ROICexc growth 5Y-24.96%
OM growth 3Y-20.2%
OM growth 5Y-27.38%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.91%
GM growth 5Y-4.79%
F-Score4
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 2.61
Debt/FCF 13.05
Debt/EBITDA 8.62
Cap/Depr 23.81%
Cap/Sales 1.05%
Interest Coverage 250
Cash Conversion 90.84%
Profit Quality N/A
Current Ratio 1.46
Quick Ratio 1.1
Altman-Z 1.45
F-Score4
WACC5.71%
ROIC/WACC0.28
Cap/Depr(3y)17.3%
Cap/Depr(5y)18.56%
Cap/Sales(3y)0.68%
Cap/Sales(5y)0.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-107.26%
EPS 3Y-14.01%
EPS 5Y-25.94%
EPS Q2Q%-320.69%
EPS Next Y-46.24%
EPS Next 2Y22.37%
EPS Next 3Y14.6%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.97%
Revenue growth 3Y-4.03%
Revenue growth 5Y-7.26%
Sales Q2Q%-0.13%
Revenue Next Year12.74%
Revenue Next 2Y10.51%
Revenue Next 3Y6.25%
Revenue Next 5Y-0.46%
EBIT growth 1Y-33.16%
EBIT growth 3Y-23.42%
EBIT growth 5Y-32.65%
EBIT Next Year77.35%
EBIT Next 3Y38.67%
EBIT Next 5Y20.31%
FCF growth 1Y-1.95%
FCF growth 3Y-5.93%
FCF growth 5Y-18.11%
OCF growth 1Y4.56%
OCF growth 3Y-6.69%
OCF growth 5Y-17.45%